Clinical Trials Sponsored by Pharmena North America

Total 566 results

Loci Orthopaedics
North American Science Associates Ltd.

Active, not recruiting

Thumb Hemi-Arthroplasty With Natural Kinematics (THANKS) Trial (THANKS)

Osteoarthritis Thumb Base Joint

Belgium
Mitsubishi Tanabe Pharma America Inc.

Active, not recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

EPP | XLP

United States, Germany, Japan, Spain, Italy, Sweden, Australia, Canada, Norway, United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis

Spain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States, Canada, Japan, France, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Mass Balance Study With MT-7117 (MT-7117 MB)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Vasomotor Symptoms (VMS)

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria

EPP | XLP

Spain, United States, Germany, Norway, Italy, Australia, Canada, Japan, Sweden, United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Mass Balance Study With MT-8554 (MT-8554 MB)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

Mild and Moderate Hepatic Impairment

United States
Asahi Kasei Pharma America Corporation

Completed

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Severe Sepsis | Coagulopathy

Korea, Republic of, United States, Taiwan, Netherlands, United Kingdom, Australia, Canada, Belgium, Israel, Spain, New Zealand, France, Brazil, India, Argentina, Bulgaria, Croatia, Czechia, Finland, Germany, Hungary, Peru, Russian Federation and more
Asahi Kasei Pharma America Corporation

Withdrawn

The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy (Scarlet2)

Sepsis and Coagulopathy
Mitsubishi Tanabe Pharma America Inc.

Recruiting

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP (INSPIRE)

Erythropoietic Protoporphyria (EPP) | X-Linked Protoporphyria (XLP)

United States, Spain, France, United Kingdom, Japan, Italy, Australia, Bulgaria, Czechia, Netherlands, Poland
Mitsubishi Tanabe Pharma America Inc.

Recruiting

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Spinal Cord Injury

United States, Canada, Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

Erythropoietic Protoporphyria (EPP)

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Korea, Republic of, Canada, Germany, Japan, Italy, Switzerland
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Endometrial Related Pain

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Canada, Japan, France, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor (MT-7117 BA DDI)

Healthy Volunteer

Germany
Mitsubishi Tanabe Pharma America Inc.

Completed

Definitive QT Study With MT-8554 (MT-8554 DQT)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Renal Impairment | Normal Renal Function

Germany
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Canada, Japan, Germany, Korea, Republic of, Switzerland
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury

Spinal Cord Injury

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects

Healthy

United Kingdom
Clinical Testing of Beverly Hills
Merz North America, Inc.

Not yet recruiting

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Glabellar Frown Lines

United States
Colorado State University
Wild Blueberry Association of North America

Recruiting

Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women

Hypertension | Aging | Endothelial Dysfunction | Men

United States
University Medical Center Groningen
Fresenius Medical Care North America

Completed

Immunoadsorption in Anti-GBM Glomerulonephritis.

Anti-glomerular Basement Membrane Glomerulonephritis

Netherlands
Blessing Corporate Services, Inc
Takeda Pharmaceuticals North America, Inc.

Withdrawn

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Pneumonia, Viral | Covid19

United States
Mayo Clinic
Grifols Shared Services North America; Option Care

Terminated

IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy

Autoimmune Epilepsy

United States
Dartmouth-Hitchcock Medical Center
Takeda Pharmaceuticals North America, Inc.

Completed

Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Goldman, Butterwick, Fitzpatrick and Groff
Merz North America, Inc.

Completed

A Single-Center Investigator-Initiated Evaluator-Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite With and Without Triamcinolone Acetate for the Treatment of Volume Loss to Dorsum Areas of the Hands

Volume Loss to Dorsum of Hands

United States
University of Calgary
Orthopaedic Trauma Association; AO North America

Completed

Comparative Study of Fixation or Fusion of Calcaneal Fractures (Sanders IV)

Fractures, Comminuted | Fracture Fixation, Internal

Canada
Ercan OK
Fresenius Medical Care North America

Completed

Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis

End-Stage Renal Disease

Turkey
University of North Carolina, Chapel Hill
Otsuka America Pharmaceutical

Completed

Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact

Healthy

United States
University of California, Irvine
Radiological Society of North America

Recruiting

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Lung Cancer

United States
Medical College of Wisconsin
Radiological Society of North America

Active, not recruiting

Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Refractory Ascites

United States
University of North Carolina, Chapel Hill
Otsuka America Pharmaceutical

Completed

Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders (TROUPER)

Congestive Heart Failure

United States
University of South Florida
Takeda Pharmaceuticals North America, Inc.

Completed

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

Gout

United States
University of North Carolina, Chapel Hill
Otsuka America Pharmaceutical

Completed

Pilot Study of Using Copeptin to Predict Response to Tolvaptan

Heart Diseases | Cardiovascular Diseases | Heart Failure

United States
Merz North America, Inc.
HealthCore-NERI; Cmed Clinical Services

Terminated

Neurogenic Dysphonia/Dysphagia Registry (StrongVoice)

Neurogenic Dysphonia | Neurogenic Dysphagia

United States
University of California, Davis
Radiological Society of North America

Completed

CTP Imaging of Lung Cancer (CTPLC)

Non Small Cell Lung Cancer

United States
East Tennessee State University
Takeda Pharmaceuticals North America, Inc.

Completed

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

Diabetes Type 2

United States
Cedars-Sinai Medical Center
Takeda Pharmaceuticals North America, Inc.

Completed

Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)

Constipation-predominant Irritable Bowel Syndrome

United States
Henry Ford Health System
Takeda Pharmaceuticals North America, Inc.

Completed

Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia

Insomnia

United States
Medical University of Graz
Fresenius Medical Care North America

Completed

Elimination of Albumin-Bound Substances by MARS and Prometheus

Liver Failure

Austria
Henry Ford Health System
Takeda Pharmaceuticals North America, Inc.

Completed

Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation (PEG)

Colonoscopy

United States
Pennington Biomedical Research Center
Takeda Pharmaceuticals North America, Inc.

Completed

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

Diabetes Mellitus, Type 2

United States
Fresenius Medical Care North America
Medical Nutrition USA, Inc.

Terminated

ProStat Supplementation in Dialysis Patients

Malnutrition | ESRD

United States

Clinical Trials Sponsored by Pharmena North America

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations